Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054275
Status:
COMPLETED
Last Update Posted:
2016-02-17
First Post:
2003-02-05
Brief Title:
Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Sponsor:
Paula Silverman MD
Organization:
Case Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2003-02-05
First Submit QC Date:
February 5 2003
Study First Post Date:
2003-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-03-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-02-15
Last Update Post Date:
2016-02-17
Last Update Post Date Type:
ESTIMATED